Eagle Pharmaceuticals, Inc. to Present at 37th Annual J.P. Morgan Healthcare Conference
WOODCLIFF LAKE, N.J.--(BUSINESS WIRE)--Jan 2, 2019--Eagle Pharmaceuticals, Inc. (Nasdaq: EGRX) (“Eagle” or the “Company”) today announced that Scott Tarriff, Chief Executive Officer, and Pete Meyers, Chief Financial Officer, will present at the 37th Annual J.P. Morgan Healthcare Conference as follows:
The presentation will be webcast live at the aforementioned time, and archived for 30 days thereafter, via the Company’s website at www.eagleus.com, under the Investors Section.
About Eagle Pharmaceuticals, Inc.
Eagle is a specialty pharmaceutical company focused on developing and commercializing injectable products that address the shortcomings, as identified by physicians, pharmacists and other stakeholders, of existing commercially successful injectable products. Eagle’s strategy is to utilize the FDA’s 505(b)(2) regulatory pathway. Additional information is available on the Company’s website at www.eagleus.com.
View source version on businesswire.com:https://www.businesswire.com/news/home/20190102005139/en/
CONTACT: Investor Relations for Eagle Pharmaceuticals, Inc:
Lisa M. Wilson
KEYWORD: UNITED STATES NORTH AMERICA CALIFORNIA NEW JERSEY
INDUSTRY KEYWORD: HEALTH CLINICAL TRIALS PHARMACEUTICAL
SOURCE: Eagle Pharmaceuticals, Inc.
Copyright Business Wire 2019.
PUB: 01/02/2019 07:00 AM/DISC: 01/02/2019 07:01 AM